CRP and juvenile idiopathic arthritis: Of note, there were also no significant differences in baseline clinical characteristics with the remaining portion of the cohort excluded from this work (n = 38) including JIA subtype, age, gender, MTX route of administration, MD-VAS, PT-VAS, CHAQ, baseline active joint count, baseline JADAS-71, ESR or CRP.